PASG Q3 2021 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$28M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$47M

Net Income

-$47M

EPS (Diluted)

$-18.84

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$53M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$391M

Total Liabilities

$29M

Stockholders' Equity

$362M

Cash & Equivalents

$163M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$47M	-$29M	-64.5%
Net Income	-$47M	-$29M	-64.4%